---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-322877"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:54:35.303850+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Immunome prices $400M public offering of 18.6M shares at $21.50 per share

## Summary
- Public offering of 18,625,000 shares at $21.50/share; gross proceeds ~$400M.
- Underwriters granted 30-day option for up to 2,793,750 additional shares at same price.
- Offering expected to close December 18, 2025; joint bookrunners include Leerink, J.P. Morgan, TD Cowen, Goldman Sachs, Guggenheim.
- All shares sold by Immunome; proceeds before underwriting discounts and expenses.

## SEC filing metadata
- accession: 0001193125-25-322877
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000119312525322877/0001193125-25-322877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000119312525322877/d27244d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-322877
- JSON: https://secwatch.observer/filing/0001193125-25-322877.json
- Plain text: https://secwatch.observer/filing/0001193125-25-322877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.